InMed Pharmaceuticals Inc. (INM)

InMed Pharmaceuticals Statistics

Total Valuation

INM has a market cap or net worth of $5.87 million. The enterprise value is -$4.66 million.

Market Cap	5.87M
Enterprise Value	-4.66M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

INM has 2.38 million shares outstanding. The number of shares has increased by 156.13% in one year.

Current Share Class	2.38M
Shares Outstanding	2.38M
Shares Change (YoY)	+156.13%
Shares Change (QoQ)	+36.15%
Owned by Insiders (%)	0.20%
Owned by Institutions (%)	5.19%
Float	2.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.45
Forward PS	n/a
PB Ratio	0.34
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.99, with a Debt / Equity ratio of 0.06.

Current Ratio	6.99
Quick Ratio	6.30
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -72.10% and return on invested capital (ROIC) is -40.66%.

Return on Equity (ROE)	-72.10%
Return on Assets (ROA)	-36.12%
Return on Invested Capital (ROIC)	-40.66%
Return on Capital Employed (ROCE)	-57.63%
Revenue Per Employee	$380,203
Profits Per Employee	-$627,856
Employee Count	13
Asset Turnover	0.36
Inventory Turnover	2.93

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.79% in the last 52 weeks. The beta is 0.38, so INM's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-42.79%
50-Day Moving Average	2.25
200-Day Moving Average	2.88
Relative Strength Index (RSI)	63.31
Average Volume (20 Days)	112,460

Short Selling Information

The latest short interest is 17,958, so 0.75% of the outstanding shares have been sold short.

Short Interest	17,958
Short Previous Month	25,578
Short % of Shares Out	0.75%
Short % of Float	0.75%
Short Ratio (days to cover)	0.41

Income Statement

In the last 12 months, INM had revenue of $4.94 million and -$8.16 million in losses. Loss per share was -$8.36.

Revenue	4.94M
Gross Profit	1.71M
Operating Income	-7.92M
Pretax Income	-8.16M
Net Income	-8.16M
EBITDA	-7.71M
EBIT	-7.92M
Loss Per Share	-$8.36

Balance Sheet

The company has $11.12 million in cash and $741,262 in debt, giving a net cash position of $10.38 million or $4.35 per share.

Cash & Cash Equivalents	11.12M
Total Debt	741,262
Net Cash	10.38M
Net Cash Per Share	$4.35
Equity (Book Value)	13.43M
Book Value Per Share	6.71
Working Capital	11.03M

Cash Flow

Operating Cash Flow	-7.77M
Capital Expenditures	n/a
Free Cash Flow	-7.77M
FCF Per Share	-$3.26

Margins

Gross margin is 34.53%, with operating and profit margins of -160.20% and -165.14%.

Gross Margin	34.53%
Operating Margin	-160.20%
Pretax Margin	-165.14%
Profit Margin	-165.14%
EBITDA Margin	-155.89%
EBIT Margin	-160.20%
FCF Margin	n/a

Dividends & Yields

INM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-156.13%
Shareholder Yield	-156.13%
Earnings Yield	-142.64%
FCF Yield	-135.74%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 14, 2024. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 14, 2024
Split Type	Reverse
Split Ratio	1:20

Scores

INM has an Altman Z-Score of -10.19 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.19
Piotroski F-Score	4